psilocybin depression-treatment-study Blog Related Topics 
Canna Law Blog
FEBRUARY 24, 2020
Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver , and Santa Cruz have decriminalized psilocybin to varying degrees.
Canna Law Blog
NOVEMBER 27, 2021
DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. Notwithstanding its dubious distinction as a Schedule I drug, DMT increasingly is the subject of study for its potential efficacy in treating a wide array of mental-health conditions including depression, anxiety, and PTSD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
APRIL 24, 2023
The body of scientific evidence supporting the use of psychedelics in the treatment of PTSD, addiction, major depressive disorder, and various other mental health disorders continues to grow. Exploring UC Davis’ Previous Studies on Psychedelics and Dendrite Growth In 2018, another pivotal study led by David E.
Cannabis Law Report
JANUARY 6, 2022
Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.
Cannabis Law Report
NOVEMBER 4, 2021
The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. This blog post will discuss the rulemaking timeline and provide updates regarding policy recommendations from the five subcommittees.
Canna Law Blog
FEBRUARY 19, 2020
There is a bona fide movement underway with psilocybin. On the commercial side, well-funded private companies (for- and non-profit) are pushing ahead with Food and Drug Administration (FDA) psilocybin studies, patent acquisition, and registration of other intellectual property. Others are public already.
PrestoDoctor
NOVEMBER 9, 2022
While not as many people use psilocybin, there are many similarities between both of them. What are some of the similarities between psilocybin and THC? Now, researchers have been finding evidence of the positive effects of psilocybin and mental illness. What Is Psilocybin? Psilocybin and THC Have Neurogenic Properties.
Expert insights. Personalized for you.
130 
Let's personalize your content